By Mike Reeves | ComplianceJournal.news
The HIPAA Privacy Rule's minimum necessary standard, codified at 45 C.F.R. § 164.514(d), requires covered entities to make reasonable efforts to limit the use and disclosure of protected health information to the minimum necessary to accomplish the intended purpose. For the first twenty years of the Privacy Rule's existence, the minimum necessary standard was primarily a workforce and access control question — who in the organization could see which patient records, and under what circumstances.
AI clinical tools have made that question substantially more complicated. A clinical decision support system that analyzes a patient's complete medical record — every diagnosis, every medication, every lab result, every clinical note — to generate a treatment recommendation is using considerably more protected health information than a human clinician reviewing the same patient for a specific presenting complaint.
Where the Minimum Necessary Question Gets Hard
The minimum necessary standard has always had a professional judgment component. A treating physician who reviews a patient's complete medical history to inform a clinical decision is generally understood to be using the minimum necessary information because clinical judgment requires comprehensive context.
AI systems complicate this in two ways. First, an AI system may process patient data at a population level — analyzing thousands of records to train or refine its models — rather than accessing individual records for individual clinical decisions. Second, the data an AI system needs to perform its clinical function may be genuinely broader than what a human clinician would access for the same task.
The Business Associate Agreement Issue
The minimum necessary standard applies to business associates as well as covered entities. BAAs with AI clinical tool vendors should specifically address minimum necessary compliance — what PHI the vendor is permitted to access, how access is limited to what is required for the contracted services, and how the vendor handles PHI when refining or updating its models.
HHS OCR's 2026 enforcement priorities explicitly include AI clinical tools, and minimum necessary compliance is one of the areas OCR has indicated it will examine. Covered entities that cannot demonstrate that their AI clinical tool vendors are operating under BAAs that address minimum necessary principles are running a compliance risk that predates any specific OCR enforcement action.
This article is for informational purposes and does not constitute legal advice.